You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane

  • Technology appraisal guidance
  • Reference number: TA458
  • Published:  19 July 2017
  • Last updated:  20 November 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools and resources to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top